BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9437893)

  • 1. [Detection of telomerase activity and its clinical application].
    Ohyashiki K; Ohyashiki JH; Yahata N; Toyama K
    Rinsho Byori; 1997 Dec; 45(12):1133-41. PubMed ID: 9437893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of in situ TRAP assay detecting telomerase activity in cell].
    Ohyashiki K; Yahata N; Ohyashiki JH
    Nihon Rinsho; 1998 May; 56(5):1159-64. PubMed ID: 9613114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
    Fajkus J
    Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
    Liu Y; Wu BQ; Zhong HH; Xu ML; Fang WG
    Pathol Int; 2010 May; 60(5):386-94. PubMed ID: 20518889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The advantage of an in situ TRAP assay for the detection of telomerase activity using bronchial washings obtained from lung cancer patients].
    Yahata N; Ohyashiki K; Kato H; Toyama K
    Nihon Rinsho; 1998 May; 56(5):1272-7. PubMed ID: 9613136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
    Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
    Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase: is it the future diagnostic and prognostic tool in human cancer?
    Mabruk MJ; O'Flatharta C
    Expert Rev Mol Diagn; 2005 Nov; 5(6):907-16. PubMed ID: 16255632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time telomeric repeat amplification protocol using the duplex scorpion and two reverse primers system: the high sensitive and accurate method for quantification of telomerase activity.
    Huang YP; Liu ZS; Tang H; Liu M; Li X
    Clin Chim Acta; 2006 Oct; 372(1-2):112-9. PubMed ID: 16714009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.
    Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; Kato H; Wright WE; Shay JW
    Cancer Res; 1997 Jun; 57(11):2100-3. PubMed ID: 9187102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity during carcinogenesis in the bronchus.
    Kakihana M; Yahata N; Hirano T; Honda H; Ikeda N; Kawate N; Konaka C; Ebihara Y; Ohyashiki K; Kato H
    Oncol Rep; 2002; 9(1):43-9. PubMed ID: 11748453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of telomerase activity and telomere function in cancer.
    Gordon KE; Parkinson EK
    Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of telomerase activity of exfoliated cells in bile and its clinical impact].
    Yu SA; Peng CH; Wu RJ; Zheng ZD; Chen K; Fu ZN
    Ai Zheng; 2002 Feb; 21(2):177-80. PubMed ID: 12479071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
    Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
    Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity in Malaysian patients with central nervous system tumors.
    Isa MN; Sulong S; Sidek MR; George PJ; Abdullah JM
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):872-6. PubMed ID: 15115103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application].
    Ohyashiki K; Yahata N; Iwama H; Aizawa T; Miki M
    Nihon Rinsho; 1998 May; 56(5):1299-303. PubMed ID: 9613141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization.
    Heine B; Hummel M; Demel G; Stein H
    J Pathol; 1998 Jun; 185(2):139-44. PubMed ID: 9713339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.